The National Institute of Clinical Research is a physician owned and managed, independent, multi-site clinical Trial Management Organization. NICR specializes in clinical trial management for our affiliated, multi-specialty network spanning from Bakersfield in northern California, east to Riverside/San Bernardino and south to San Diego. NICR’s network also includes management of sites in Las Vegas, Nevada and southern Mississippi, centered in Hattiesburg.
We are leaders in planning, organizing, and managing multi-therapeutic pharmaceutical, device, and biotech clinical research trials.
The professional affiliations enable NICR to undertake multiple levels of research and planning necessary for any types of clinical trial. The solid track record of the physicians and researchers from these renowned institutions, coupled with their full scale, state-of-the-art medical capabilities help guarantee that NICR clients will receive the highest quality clinical trials possible.
NICR is committed to the timely, cost-effective, high quality conduct of clinical trials, while maintaining superior levels of communication, accountability, and flexibility with our clients. We strive to combine the highest level of performance with the highest level of client service and satisfaction.
Since 1997, NICR has conducted over 154 clinical trials for the following sponsors: Merck & Co., Inc. HMRI/Quintiles, Bristol-Myers Squibb Pharmaceutical, Pharmacia & Upjohn Inc., Omrix Biopharmaceuticals, Inc., Tap Holdings Inc./Phoenix International, Abbot Laboratories/Paragon Biomedical, Inc., Ortho-McNeil Pharmaceutical, Advanced Biologics, Gilead Sciences, Inc., BioCryst Pharmaceuticals, Inc., Wyeth-Ayerst Research Co., Novartis Pharmaceutical Corp., Chiron Pharmaceutical, Chembiomed Pharmaceutical, Sterling Pharmaceutical Co., Miles Pharmaceutical Co., Fujisawa USA, Inc., Burroughs Welcome Co., Roche Laboratories, Univax Biologics, Inc., SangStat Corp., Neurex Corp, Pfizer, Sandoz Pharmaceuticals, Artificial Kidney Foundation, Transplantation Technologies, and Pasteur Merieux Connaught Transplantation.